START FREE TRIAL

Is Nvidia’s China Comeback A Win Or A Structural RISK?

After months of lobbying, Nvidia Corp (NASDAQ:NVDA) finally received U.S. approval to resume selling its H200 artificial intelligence chips to China. On the surface,...

Did The Rio Tinto–Glencore Deal Fail Because Copper Is TOO Strategic?

Rio Tinto and Glencore walked away from merger talks...

Is Nvidia’s China Comeback A Win Or A Structural RISK?

After months of lobbying, Nvidia Corp (NASDAQ:NVDA) finally received...

Hims & Hers Just Went Big on Cancer—But the DOJ Is Watching

Hims & Hers used the Super Bowl stage to...

Verizon’s Turnaround Has a Blind Spot — & It Isn’t the CEO Exit

Sowmyanarayan Sampath is stepping down as CEO of Verizon’s...

Is Microsoft Winning AI — Or Just Funding Its Rivals?

Microsoft continues to expand its AI footprint, but user...

Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?

Pfizer just released mid-stage data from its Metsera-acquired obesity...

Technology & AI

Consumer & Retail

Healthcare

Recent Posts

Did The Rio Tinto–Glencore Deal Fail Because Copper Is TOO Strategic?

Rio Tinto and Glencore walked away from merger talks that would have reshaped global copper supply. The deal collapsed...

Is Nvidia’s China Comeback A Win Or A Structural RISK?

After months of lobbying, Nvidia Corp (NASDAQ:NVDA) finally received U.S. approval to resume selling its H200 artificial intelligence chips...

Hims & Hers Just Went Big on Cancer—But the DOJ Is Watching

Hims & Hers used the Super Bowl stage to push its latest offering: a $689 early cancer detection test....

Verizon’s Turnaround Has a Blind Spot — & It Isn’t the CEO Exit

Sowmyanarayan Sampath is stepping down as CEO of Verizon’s Consumer Group, handing interim control to transformation chief Alfonso Villanueva....

Is Microsoft Winning AI — Or Just Funding Its Rivals?

Microsoft continues to expand its AI footprint, but user engagement with Copilot is falling fast. Despite 15 million paid...

Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?

Pfizer just released mid-stage data from its Metsera-acquired obesity drug showing 12.3% weight loss at 28 weeks with monthly...

Is The Devon + Coterra $21 Billion Merger About Growth — Or Running Out of Rock?

Devon Energy just announced a $21.4 billion all-stock acquisition of Coterra, positioning itself as one of the largest U.S....

Is Apple Outflanking Meta With This Q.AI Move?

Apple acquired Israeli startup Q.AI for close to $2B, locking down patents around “facial skin micro movements” that enable...

Is Amazon’s $50 Billion OpenAI Deal Really About AI — Or Just AWS Market Share?

Amazon is reportedly negotiating a $50 billion investment into OpenAI, a potential anchor in a $100 billion funding round....

Amazon Just Cut 16,000—but the REAL SHIFT Is How It’s Flattening Itself

Amazon (NASDAQ:AMZN) just announced it's laying off another 16,000 corporate employees, marking the second major workforce reduction in just...

UnitedHealth CRASHES After Shocking Medicare Ruling — The Fallout Explained!

When a 0.09% number sends $96 billion out the window, you know something serious just happened. On January 27,...

Is Pinterest Shrinking or Scaling? THIS AI SHIFT Tells the Story!

Pinterest (NYSE:PINS) is the latest tech player to join the layoff wave, announcing plans to reduce its workforce by...

Popular

spot_img